Subscribe
Sign In
Menu
Search
Financial Times
myFT
Search the
FT
Search
Search the
FT
Search
Close
Home
World
US
Companies
Tech
Markets
Climate
Opinion
Lex
Work & Careers
Life & Arts
HTSI
Sign In
Subscribe
Markets
Markets Data
Company Announcements
Financial Times
Close
International Edition
UK Edition
Search the
FT
Search
Top sections
Home
Show more World link
World
Israel-Hamas war
Global Economy
UK
US
China
Africa
Asia Pacific
Emerging Markets
Europe
War in Ukraine
Americas
Middle East & North Africa
Show more US link
US
US Economy
Investing in America
US Companies
US Politics & Policy
US Presidential Election 2024
Show more Companies link
Companies
Energy
Financials
Health
Industrials
Media
Professional Services
Retail & Consumer
Tech Sector
Telecoms
Transport
Show more Tech link
Tech
Artificial intelligence
Semiconductors
Cyber Security
Social Media
Show more Markets link
Markets
Alphaville
Markets Data
Cryptofinance
Capital Markets
Commodities
Currencies
Equities
Wealth Management
Moral Money
ETF Hub
Fund Management
Trading
Climate
Show more Opinion link
Opinion
Columnists
The FT View
The Big Read
Lex
Obituaries
Letters
Lex
Show more Work & Careers link
Work & Careers
Business School Rankings
Business Education
Europe's Start-Up Hubs
Entrepreneurship
Recruitment
Business Books
Business Travel
Working It
Show more Life & Arts link
Life & Arts
Arts
Books
Food & Drink
FT Magazine
House & Home
Style
Travel
FT Globetrotter
Show more Personal Finance link
Personal Finance
Property & Mortgages
Investments
Pensions
Tax
Banking & Savings
Advice & Comment
Next Act
HTSI
Special Reports
FT recommends
Alphaville
FT Edit
Lunch with the FT
FT Globetrotter
#techAsia
Moral Money
Visual and data journalism
Newsletters
Video
Podcasts
News feed
FT Live Events
FT Forums
Board Director Programme
myFT Feed
Portfolio
FT Digital Edition
Crossword
Our Apps
My Account
Sign In
Company Announcements
Novozymes A/S
Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholders
Twitter
Facebook
LinkedIn
GooglePlus
Pinterest
Mar 30 2023 10:08 BST
Source: GlobeNewswire
Combination between Novozymes and Chr. Hansen approved by the Novozymes shareholders
Please read the announcement in PDF
Attachment
2023_50_Combination_between_Novozymes_and_Chr._Hansen_approved_by_the_Novozymes_shareholders
Twitter
Facebook
LinkedIn
GooglePlus
Pinterest
